Related Experiment Videos
Adequacy of hemodialysis
R M Hakim1, T A Depner, T F Parker
1Division of Nephrology, Vanderbilt University, Nashville, TN.
Summary
High mortality in end-stage renal disease (ESRD) patients on hemodialysis may stem from inadequate dialysis doses. Achieving an optimal delivered dose of hemodialysis (Kt/V ≥ 1.4) is crucial for improving patient outcomes.
Area of Science:
- Nephrology
- Renal Medicine
- Dialysis Therapy
Background:
- End-stage renal disease (ESRD) patients undergoing hemodialysis in the US exhibit high mortality rates despite technical advancements.
- Increasing comorbidities among new ESRD patients contribute to this mortality.
- Inadequate dialysis dosage is increasingly recognized as a significant factor in high ESRD mortality.
Purpose of the Study:
- To review parameters for assessing dialysis adequacy.
- To identify factors causing discrepancies between prescribed and delivered hemodialysis doses.
- To propose an optimal hemodialysis dose for improving patient morbidity and mortality.
Main Methods:
- Review of existing literature on hemodialysis adequacy parameters.
- Analysis of factors influencing hemodialysis dose delivery.
- Evidence-based proposal for an optimal delivered hemodialysis dose (Kt/V).
Main Results:
- Current hemodialysis doses in the US may be insufficient for many patients.
- A delivered hemodialysis dose of Kt/V 1.4 or greater, using biocompatible membranes, is proposed as optimal.
- Monitoring the delivery of the prescribed dialysis dose is essential.
Conclusions:
- Optimizing hemodialysis dose is critical for reducing mortality in ESRD patients.
- A delivered Kt/V of 1.4 represents a target for improved patient outcomes.
- Continuous monitoring of dialysis delivery ensures adequate treatment.